RT Journal Article
SR Electronic
T1 Lessons learnt from 288 COVID-19 international cases: importations over time, effect of interventions, underdetection of imported cases
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.24.20027326
DO 10.1101/2020.02.24.20027326
A1 Pinotti, Francesco
A1 Di Domenico, Laura
A1 Ortega, Ernesto
A1 Mancastroppa, Marco
A1 Pullano, Giulia
A1 Valdano, Eugenio
A1 Boëlle, Pierre-Yves
A1 Poletto, Chiara
A1 Colizza, Vittoria
YR 2020
UL http://medrxiv.org/content/early/2020/02/25/2020.02.24.20027326.abstract
AB 288 cases have been confirmed out of China from January 3 to February 13, 2020. We collected and synthesized all available information on these cases from official sources and media. We analyzed importations that were successfully isolated and those leading to onward transmission. We modeled their number over time, in relation to the origin of travel (Hubei province, other Chinese provinces, other countries) and interventions. We characterized importations timeline to assess the rapidity of isolation, and epidemiologically linked clusters to estimate the rate of detection. We found a rapid exponential growth of importations from Hubei, combined with a slower growth from the other areas. We predicted a rebound of importations from South East Asia in the upcoming weeks. Time from travel to detection has considerably decreased since the first importation, however 6 cases out of 10 were estimated to go undetected. Countries outside China should be prepared for the possible emergence of several undetected clusters of chains of local transmissions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partially funded by: the ANR project DATAREDUX (ANR-19-CE46-0008-03); the EU grant MOOD (H2020-874850); the Municipality of Paris through the programme Emergence(s).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData were collected by the authors and made publicly available online. https://docs.google.com/spreadsheets/d/1X_8KaA7l5B_JPpwwV3js1L6lgCRa3FoH-gMrTy2k4Gw/edit#gid=486974430